[1]杨水秀,周贤位,张明玲,等.HIV血液透析患者深静脉血栓形成的危险因素分析[J].医学信息,2020,33(24):80-83.[doi:10.3969/j.issn.1006-1959.2020.24.022]
　YANG Shui-xiu,ZHOU Xian-wei,ZHANG Ming-ling,et al.Analysis of Risk Factors of Deep Vein Thrombosis in HIV Hemodialysis Patients[J].Medical Information,2020,33(24):80-83.[doi:10.3969/j.issn.1006-1959.2020.24.022]
点击复制

HIV血液透析患者深静脉血栓形成的危险因素分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年24期
页码:
80-83
栏目:
论著
出版日期:
2020-12-15

文章信息/Info

Title:
Analysis of Risk Factors of Deep Vein Thrombosis in HIV Hemodialysis Patients
文章编号:
1006-1959（2020）24-0080-04
作者:
杨水秀1; 周贤位2; 张明玲1; 冉 瑶1
1.贵州省贵阳市公共卫生救治中心血透室，贵州 贵阳 550001； 2.贵州省贵阳市第一人民医院检验科，贵州 贵阳 550005
Author(s):
YANG Shui-xiu1; ZHOU Xian-wei2; ZHANG Ming-ling1; RAN Yao1
1.Hemodialysis Room of Guiyang Public Health Clinical Center,Guiyang 550001,Guizhou,China; 2.Department of Laboratory Medicine,the first People’s Hospital of Guiyang City,Guiyang 550001,Guizhou,China
关键词:
HIV; 血液透析; 中心静脉导管留置; 深静脉血栓
Keywords:
HIV; Hemodialysis; Central venous catheter indwelling; Deep vein thrombosis
分类号:
R512.91
DOI:
10.3969/j.issn.1006-1959.2020.24.022
文献标志码:
A
摘要:
目的 分析艾滋病（HIV）患者合并肾衰竭需急诊血液透析于股静脉临时中心静脉导管置入术后发生深静脉血栓栓塞的风险及危险因素，为早期发现及时采取临床防治措施提供参考。方法 选择2015年6月~2018年5月贵州省各地就诊于贵阳市公共卫生救治中心需接受血液透析首次留置股静脉临时中心静脉导管的66例HIV患者的临床资料，将发生深静脉血栓（DVT）的26例作为HIVDVT组，未发生深静脉血栓者的40例设为HIV非DVT组，同期选取非HIV感染的血液透析患者93例作为对照组；分析合并HIV感染的血液透析患者发生DVT的风险及相关危险因素。结果 HIV患者DVT风险为39.39%，高于对照组的12.90%，差异有统计学意义（P＜0.05）；且导管留置第9天时易发生DVT。HIVDVT组与HIV非DVT组年龄、体重指数、置管前水肿、抗反转录病毒治疗（ART）、白细胞、红细胞、血红蛋白、血小板计数、凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原、尿素、血肌酐、β2-微球蛋白、总胆固醇、甘油三酯、低密度脂蛋白、高密度脂蛋白、载脂蛋白A比较，差异无统计学意义（P＞0.05），两组ART、CD4+T淋巴细胞计数、D-二聚体、载脂蛋白B、置管天数比较，差异有统计学意义（P＜0.05）；多因素Logistic回归分析显示，CD4+T淋巴细胞计数、D-二聚体是HIV血透患者股静脉临时中心静脉导管留置后发生DVT的独立危险因素，载脂蛋白B为独立保护因素。结论 与非HIV感染的血液透析患者相比，HIV血透患者中心静脉导管留置后易发生DVT，其中CD4+T淋巴细胞计数、D-二聚体为其独立危险因素，载脂蛋白B为独立保护因素，对此类患者需早期干预，降低其DVT发生率。
Abstract:
Objective To analyze the risk and risk factors of deep vein thromboembolism in patients with AIDS (HIV) complicated with renal failure requiring emergency hemodialysis after femoral vein temporary central venous catheter placement, and provide reference for early detection and timely clinical prevention and treatment measures.Methods The data of 66 HIV patients who received hemodialysis in Guiyang Public Health Clinical Center from June 2015 to May 2018 were reviewed.26 patients of deep venous thrombosis (DVT) were included inHIV DVT group,and the other 40 cases were selected asHIV nonDVT group.At the same time,93 hemodialysis patients for non HIV infectionwere selected as control group.To analyze the risk of DVT and related risk factors in hemodialysis patients with HIV infection.Results The risk of DVT in HIV patients was 39.39%, which was higher than 12.90% in the control group,the difference was statistically significant (P<0.05); and DVT was prone to occur on the 9th day of catheter indwelling. HIVDVT group and HIV non-DVT group age, body mass index, pre-intubation edema, antiretroviral therapy (ART), white blood cells, red blood cells, hemoglobin, platelet count, prothrombin time, activated partial thromboplastin time, fibrin,there was no statistically significant difference between the original, urea, blood creatinine, β2-microglobulin, total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, and apolipoprotein A (P>0.05). The two groups of ART , CD4+ T lymphocyte count, D-dimer, apolipoprotein B, and the number of days of catheterization, the difference was statistically significant (P<0.05);Multivariate Logistic regression analysis showed that CD4+T lymphocyte count and D-dimer were independent risk factors for DVT after femoral vein indwelling temporary central venous catheter in HIV hemodialysis patients, and apolipoprotein B was an independent protective factor.Conclusion Compared with non-HIV-infected hemodialysis patients, HIV hemodialysis patients are more likely to develop DVT after central venous catheter indwelling. CD4+T lymphocyte count and D-dimer are independent risk factors, and apolipoprotein B is independent. Protective factors, such patients need early intervention to reduce the incidence of DVT.

参考文献/References:

[1]中华医学会感染病学分会艾滋病丙肝学组,中国疾病预防与控制中心.中国艾滋病诊疗指南(2018版)[J].中国艾滋病性病,2018,24(12):1266-1282. [2]Jain S,Gautam V,Naseem S.Acute-phase:As diagnostic tool[J].J Pharm Bioallied Sci,2011,3(1):118-127. [3]李航,张福杰,卢洪洲,等.HIV感染合并慢性肾脏病患者管理专家共识[J].中国艾滋病性病,2017(6):578-580． [4]Jin L,Wang J,Wu C,et al.Femoral Arteriovenous Fistula Associated With Leg Swelling 6 Months After Removal of a Hemodialysis Catheter:A Case Report[J].Medicine (Baltimore),2015,94(40):e1738. [5]Durand M,Sinyavskaya L,Jin YL,et al.Incidence of Venous Thromboembolism in Patients Living with HIV:A Cohort Study[J].AIDS PATIENT CARE and STDs,2019,33(11):455-458. [6]Rokx C,Borjas Howard JF,Smit C,et al.Risk of recurrent venous thromboembolism in patients with HIV infection:A nationwide cohort study[J].PLoS Medicine,2020,17(5):e1003101. [7]中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南（第三版)[J].中国血管外科杂志,2017,9(4):250-257. [8]赵宁,张加乐,江婷,等.ICU患者外周静脉置入中心静脉导管相关上肢深静脉血栓形成的危险因素[J].中华危重急救医学,2017,29(2):167-171. [9]Vanholder R,Canaud B,Fluck R,et al.Catheter-related blood stream infections(CRBCI):a European view[J].Nephrol Dial Transplant,2010,25(6):1753-1756． [10]薛箫,林朝霞,陈俊,等.维持性血透患者股静脉留置中心静脉导管致深静脉血栓的临床分析[J].血栓与止血学,2017,23(4):621-627. [11]许丽文.ICU预防CRRT患者下肢深静脉血栓护理干预[J].医学信息,2015,28(41):349-350. [12]金其庄,王玉柱,叶朝阳,等.中国血液透析用血管通路专家共识（第2版）[J].中国血液净化,2019,18(6):365-381. [13]Crum-Cianflone NF,Weeles J,Bavaro M.Thromboses among HIV-infected patients during the highly active antiretroviral therapy era[J].AIDS Patient Care STDS,2008,22(10):771-778. [14] Wang P,Kandemir U,Zhang B,et al.Incidence and Risk Factors of Deep Vein Thrombosis in Patients With Pelvic and Acetabular Fractures[J].Clin Appl Thromb Hemost,2019(25):1076029619845066. [15]尹星华,周一新,唐杞衡,等.人工髋膝关节置换术后症状性静脉血栓栓塞性疾病的危险因素分析[J].中国矫形外科杂志,2016,24(19):1765-1769. [16]杨玉春,汪小海,张咏梅,等.老年患者全麻下全髋置换术后下肢深静脉血栓发生情况及危险因[J].局解手术学杂志,2019,28(2):108-111. [17]Kruger PC,Eikelboom JW,Douketis JD,et al.Deep vein thrombosis: update on diagnosis and management[J].Medical Journal of Australia,2019,210(11):516-524. [18]Cheng Y,Cui T,Fu P,et al.Dyslipidemia is associated with tunneled cuffed catheter relatedcentral venous thrombosis in hemodialysis patients:a retrospective,multicenter study[J].Artif Organs,2013,37(8):E155-E161. [19]宋义祥.活化部分凝血功能时间、纤维蛋白原、载脂蛋白A1/B与冠心病及冠脉病变程度的相关性分析[D].吉林大学,2013. [20]邵旭霞,陈江华.终末期肾病（ESRD）血液透析患者早期死亡及相关因素分析[D].浙江大学,2016. [21]Kim SJ,Sabharwal S.Risk factors for venous thromboembolism in hospitalized children and adolescents:a systemic review and pooled analysis[J].Journal of Pediatric Orthopaedics B,2014,23(4):389-393.

相似文献/References:

[1]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
　XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Medical Information,2018,31(24):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[2]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
　ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Medical Information,2018,31(24):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[3]罗纯生,刘 静.三种不同免疫检验方式在HIV检测中的可靠性观察[J].医学信息,2022,35(10):174.[doi:10.3969/j.issn.1006-1959.2022.10.045]
　LUO Chun-sheng,LIU Jing.Reliability Observation of Three Different Immunoassay Test Methods in HIV Detection[J].Medical Information,2022,35(24):174.[doi:10.3969/j.issn.1006-1959.2022.10.045]
[4]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
　WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Medical Information,2018,31(24):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[5]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
　FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Medical Information,2019,32(24):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[6]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
　JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Medical Information,2018,31(24):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[7]卢 冰,汪昭民,李 洁,等.1例HIV感染并发肛周脓肿者治疗的分析[J].医学信息,2019,32(07):187.[doi:10.3969/j.issn.1006-1959.2019.07.061]
[8]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
　ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Medical Information,2019,32(24):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
[9]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
　XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Medical Information,2019,32(24):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
[10]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
　YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Medical Information,2019,32(24):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]

更新日期/Last Update: 1900-01-01